GVR Report cover North America IV Hydration Therapy Market Size, Share & Trends Report

North America IV Hydration Therapy Market (2026 - 2033) Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By Provider Type, By End Use, By Country, And Segment Forecasts

North America IV Hydration Therapy Market Summary

The North America IV hydration therapy market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.56 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. The market is primarily driven by heightened consumer emphasis on proactive health management, the shift toward preventive wellness, and increasing demand for convenient, on-demand healthcare services.

Key Market Trends & Insights

  • U.S. dominated the North America IV hydration therapy market with the largest revenue share of 83.3% in 2025.
  • Based on service, the energy boosters segment led the market with the largest revenue share of 25.44% in 2025.
  • Based on provider type, the physical providers segment led the market with the largest revenue share of 56.6% in 2025.
  • Based on the component, the medicated segment accounted for the largest market revenue share in 2025.
  • Based on end use, the hospitals & clinics segment accounted for the largest market revenue share in 2025.

Market Size & Forecast

  • 2025 Market Size: USD 1.35 Billion
  • 2033 Projected Market Size: USD 2.56 Billion
  • CAGR (2026-2033): 8.6%


Post-pandemic health consciousness has significantly accelerated the adoption of intravenous (IV) hydration as a lifestyle and recovery solution. In parallel, the growing incidence of fatigue, migraines, and nutrient deficiencies has expanded the therapeutic scope of IV therapy beyond traditional clinical use.

The North America IV hydration therapy industry is rising, owing to the increasing prevalence of chronic diseases such as cancer and diabetes. According to the CDC estimates of February 2024, around 129 million people in the US have at least 1 major chronic disease, creating a strong demand for effective healthcare solutions. IV hydration therapy is a crucial player, offering a direct and quick way to address the consequences and management of chronic diseases. It becomes a valuable tool in improving the well-being of individuals facing these conditions. As chronic diseases become more common, the market is stepping up to provide specialized care and support for those who need it. 

North America iv hydration therapy market size and growth forecast (2023-2033)

Increasing awareness of the benefits of IV hydration therapies among North America’s population is boosting the market growth. According to the National Institute of Health and Care Excellence, numerous adult patients require Intravenous (IV) fluid therapy to address to fluid and electrolyte balance. IV therapy is a therapeutic intervention that delivers fluids directly into the bloodstream to restore hydration and revitalize the body. Remarkably, IV hydration offers a faster and more complete absorption of vitamins, electrolytes, and antioxidants than oral intake, as it avoids the digestive system.

IV hydration therapy is utilized across multiple clinical areas to ensure rapid and effective fluid and electrolyte management. In emergency and critical care, it provides immediate resuscitation for trauma, shock, sepsis, and acute dehydration. For gastrointestinal disorders, it helps manage fluid loss from severe vomiting, diarrhea, or inflammatory bowel conditions. Post-surgical care relies on IV therapy to maintain fluid balance, deliver medications, and support recovery when oral intake is limited. In oncology, it prevents dehydration and fatigue during chemotherapy and radiation, while in chronic disease management, it supports patients with diabetes, renal, or cardiovascular conditions who have restricted oral intake.

The increasing demand for IV hydration therapy is also driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients’ homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services. 

Rising Adoption of Mobile IV Therapy, a Key Market Trend in North America 

Mobile IV therapy has become a key trend in the North America IV hydration therapy industry, driven by rising demand for convenience, personalized treatments, and quick recovery options. By providing hydration, vitamins, and wellness infusions directly to homes, offices, and events, these services support busy schedules, athletic recovery, immunity boosting, and hangover relief, all while ensuring safety through licensed medical professionals. Some of the recent developments include: 

  • In November 2025, First Rate Infusion & Wellness announced the launch of its mobile “Vitamins in a Bag” program across the Dallas Fort Worth region, offering on-site IV hydration and vitamin infusion services for employees. The initiative aims to support workplace wellness, improve energy and recovery, and help employers address fatigue and stress without disrupting productivity.

“Employee fatigue continues to affect multiple industries, this initiative gives companies a practical way to address dehydration, stress, and burnout while helping employees maintain energy, mental clarity, and physical recovery during demanding work schedules.”

-Teria Mullin, CRNA, FNP-C, clinical lead at First Rate Infusion & Wellness.

  • In August 2025, NextDrip Mobile IV Therapy expanded its services by opening a new location in Burbank, California, to provide mobile hydration and wellness IV therapy throughout the city and surrounding communities. The Burbank site aims to meet growing local demand for convenient, on-site IV therapy at homes, workplaces, and events, reflecting rising interest in mobile wellness services in urban markets.

  • In June 2025, Vellum Health closed its Series A funding round led by FCA Venture Partners. It launched a mobile IV care platform that integrates advanced technology, highly trained clinicians, and mobile service delivery to provide on-demand intravenous services at the bedside, aiming to expand nationally and improve patient outcomes.

"Vellum is solving real operational and clinical challenges with a patient-centered, mobile-first model. We’re excited to support their growth and believe their model is uniquely positioned to meet the needs of an evolving healthcare landscape."

- Matt King, Managing Partner at FCA Venture Partners.

Market Concentration & Characteristics

The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, the impact of regulations, the level of partnership & collaboration activities, the degree of innovation, and regional expansion. For instance, the North America IV hydration therapy industry is slightly fragmented, with many product & service providers entering the market. The degree of innovation, the level of partnerships & collaboration, and the impact of regulations on the industry are high. However, the regional expansion observes moderate growth. 

Innovation in the North America IV hydration therapy industry is rapidly advancing, driven by growing demand for personalized wellness solutions and improvements in delivery methods. For instance, in December 2024, Prime IV Hydration & Wellness launched “Power Pushes,” an innovative IV therapy that provides the same nutrient benefits as traditional drips in half the time with reduced fluid volume. This service offers tailored treatments for energy enhancement, immune support, skin revitalization, and relief from fatigue or migraines, administered by trained professionals at their franchise locations. 

North America IV Hydration Therapy Industry Dynamics

The level of partnerships and collaborations in the North America IV hydration therapy industry is moderate, reflecting a growing focus on expanding accessibility and enhancing service quality. Providers are gradually forming alliances with healthcare professionals, wellness clinics, and mobile health platforms to develop new formulations, improve delivery models, and integrate technology-enabled monitoring systems. For instance, in August 2025, PICO IV partnered with Liquivida, appointing Liquivida founder Sam Tejada as spokesperson to promote the clinical potential of its sterile CBD emulsion and raise awareness of the body's endocannabinoid system, advancing IV hydration innovation with an emphasis on safety and education. This collaboration aims to enhance provider education and integrate sterile CBD into clinical and wellness protocols nationwide.

Regulatory influence is high in this North America IV hydration therapy industry, shaped by state- and province-specific requirements governing medical procedures, clinician supervision, and telehealth integration. These rules can vary considerably, affecting scalability and compliance costs. Inconsistencies between jurisdictions pose operational friction for regional and national players.

In North America, IV hydration providers are rapidly expanding across multiple states, opening clinics and mobile services to improve accessibility, bring personalized wellness treatments closer to patients, and strengthen market presence in urban and suburban areas.

Service Insights

The energy boosters segment led the market with the largest revenue share of 25.4% in 2025, driven by rising consumer demand for quick fatigue relief, enhanced stamina, and stress management. The popularity of vitamin- and mineral-based IV formulations among working professionals, athletes, and wellness-focused consumers, along with their widespread availability across clinics and mobile IV services, further supported the segment’s dominance. 

The beauty and aesthetics segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. This growth is driven by rising demand for skin rejuvenation, anti-aging, and cosmetic wellness treatments. Increasing adoption of IV therapies offering glutathione, vitamin C, and collagen-boosting formulations, along with the expansion of med spas, wellness clinics, and mobile IV services, is accelerating growth across the region. 

Component Insights

The medicated segment led the market with the largest revenue share of 67.0% in 2025. This dominance is due to the increasing demand for medications administered through the IV route, along with key players focusing on developing customizable medicated IV hydration therapy solutions. 

The non-medicated segment is expected to grow at the fastest CAGR during the forecast period. The segment's growth can be linked to the increasing demand for therapies in beauty and energy-boosting applications. The steadily growing global population is widely adopting IV hydration therapy to hydrate their skin and maintain its natural glow. 

Provider Type Insights

The physical providers segment accounted for the largest market revenue share in 2025, driven by strong patient preference for in-clinic administration, direct medical supervision, and perceived safety and credibility. The widespread presence of hospitals, wellness clinics, and med spas, along with compliance with state-level regulations requiring licensed facilities and clinician oversight, further supported the dominance of physical providers. 

The mobile providers segment is expected to register at the fastest CAGR during the forecast period, supported by rising demand for on-demand, at-home wellness and recovery solutions. The convenience of doorstep services, growing popularity among busy professionals, athletes, and travelers, and integration with digital booking platforms are fueling their rapid adoption. 

End Use Insights

The hospitals & clinics segment accounted for the largest market revenue share in 2025. Segment growth can be attributed to their established clinical infrastructure, the availability of licensed healthcare professionals, and higher patient trust. These settings ensure compliance with regulatory standards, enable the safe administration of IV therapies, and support a broader range of treatment options than in non-clinical environments.  

North America IV Hydration Therapy Market Share

The home healthcare segment is expected to grow at the fastest CAGR over the forecast period, driven by rising demand for convenience, personalized care, and in-home wellness services. The expansion of mobile IV therapy providers, growing acceptance of at-home clinical services, and increased focus on comfort and time efficiency among urban consumers are accelerating adoption.

Country Insights 

U.S. IV Hydration Therapy Market Trends

U.S. dominated the North America IV hydration therapy market with the largest revenue share of 83.3% in 2025, driven by increasing awareness of the benefits of intravenous fluids for rapid rehydration, nutrient replenishment, and wellness applications. Rising demand from hospitals, outpatient clinics, and specialty wellness centers, coupled with the growing popularity of preventive and performance-enhancing hydration therapies, is fueling adoption. In addition, advancements in IV therapy solutions, such as vitamin-enriched fluids and portable infusion devices, along with a focus on patient comfort and minimally invasive care, are further propelling market growth across both clinical and lifestyle segments. 

The IV hydration therapy market in Canada is expected to grow at a significant CAGR during the forecast period, driven by increasing consumer awareness of wellness and preventive care, expanding mobile and clinic-based IV therapy services, and supportive healthcare regulations. Growing adoption of vitamins, hydration, and beauty-focused IV treatments, along with rising investment in employee wellness programs, is further fueling market growth.

Key North America IV Hydration Therapy Company Insights

Key players in the North America IV hydration therapy industry are adopting innovative strategies, including personalized infusion formulations, mobile and in-clinic services, and digital booking platforms, to enhance accessibility and the patient experience. Integration of smart infusion technologies and partnerships with wellness centers, fitness facilities, and luxury providers are further driving adoption and expanding market reach. 

Key North America IV Hydration Therapy Companies:

  • Baxter
  • B. Braun SE
  • Otsuka Pharmaceutical Co., Ltd.
  • Grifols, S.A.
  • Vifor Pharma Management Ltd.
  • JW Life Science Corporation
  • Amanta Healthcare
  • NexGen Health
  • Core IV Therapy, LLC
  • Drip Hydration
  • REVIV
  • Drip Hydration
  • DriPros IV Hydration Wellness
  • wHydrate
  • Renew Ketamine & Wellness Center
  • R2 Medical Clinic
  • AliveDrip
  • Hydrate IV
  • Hydration Room

Recent Developments

  • In December 2025, Hydration Room announced it has expanded to 50 clinics across California, marking a major milestone in its growth from a single home‑based IV therapy to a broad wellness network that supports proactive health.

  • In March 2025, purelyIV launched its Take-Home B12 Kit, designed to complement in-home IV hydration therapy and help clients maintain their B12 levels between sessions. The kit includes a 3-month supply of Vitamin B12 injections, syringes, alcohol pads, and a sharps container, with a free online consultation included to ensure proper usage.

  • In May 2024, XWELL, Inc. launched IV hydration drip therapy at its XpresSpa site in Miami International Airport (MIA), initiating a pilot program in collaboration with Revitalize IV Lounge. This new service provides four tailored hydration treatments aimed at enhancing energy, boosting immune health, and promoting recovery.

  • In July, 2024, ChromaDex announced the launch and nationwide availability of pharmaceutical-grade intravenous Niagen (nicotinamide riboside chloride), offering a superior, faster, and better-tolerated alternative to traditional NAD+ IV therapies for enhanced cellular health and aging benefits. 

North America IV Hydration Therapy Market Report Scope

Report Attribute

Details

Market size value in 2026

USD 1.44 billion

Revenue forecast in 2033

USD 2.56 billion

Growth rate

CAGR of 8.6% from 2026 to 2033

Base year for estimation

2025

Historical data

2021 - 2024

Forecast period

2026 - 2033

Quantitative units

Revenue in USD million/billion, and CAGR from 2026 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Service, component, provider type, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico

Key companies profiled

Baxter; B. Braun SE; Otsuka Pharmaceutical Co., Ltd.; Grifols; S.A.; Vifor Pharma Management Ltd.; JW Life Science Corporation; Amanta Healthcare; NexGen Health; Core IV Therapy, LLC; Drip Hydration; REVIV; DriPros IV Hydration Wellness; wHydrate; Renew Ketamine & Wellness Center; R2 Medical Clinic; AliveDrip; Hydrate IV; Hydration Room.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

North America IV Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America IV hydration therapymarket report based on service, component, provider type, end use, and regions.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)

    • Immune Boosters

    • Energy Boosters

    • Hydration

    • Beauty/ Aesthetics

    • Detoxification

    • Longevity/ Antiaging

    • Performance/ Athletics

    • Migraine & Pain Relief

    • Stress/Sleep/Mood Support

    • Flu/Stomach

    • Others

  • Component Outlook (Revenue, USD Million, 2021 - 2033)

    • Medicated

    • Non-medicated

  • Provider Type Outlook (Revenue, USD Million, 2021 - 2033)

    • Mobile Providers

    • Physical Providers

  • End Use Outlook (Revenue, USD Million, 2021 - 2033)

    • Hospitals & Clinics

    • Wellness Centers and Spas

    • Home Healthcare

    • Others

  • Country Outlook (Revenue, USD Million, 2021 - 2033)

    • U.S.

    • Canada

    • Mexico

Frequently Asked Questions About This Report

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo